POSTER SESSION IV
Tuesday, March 1, 2011   1:00 PM - 4:30 PM
Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...
Title and Authors
Trends in Thyroid Pathology. Steady Prevalence of PTC and Rise of Nodular Goiter in Thyroidectomies.
S Lino-Silva, E Medina-Lopez, D Acuna-Gonzalez, O Gonzalez-Trevino, A Gamboa-Dominguez - INCMN Salvador Zubiran, Mexico City, DF, Mexico
Claudin-1 and -7 Expression in Solid Cell Nests of the Thyroid: An Enigmatic Analogy with Papillary Carcinoma.
C Colato, A Fierabracci, A Dardano, F Monzani, M Chilosi, G Martignoni, F Menestrina, M Ferdeghini - University of Verona, Italy; Children's Hospital Bambino Gesu, IRCCS, Rome, Italy; University of Pisa, Italy
AQP4 and Histone H1.5 Immunostaining Can Distinguish Benign Oncocytic Follicular Lesions from Oncocytic Follicular Carcinoma.
J Chepovetsky, DE Burstein, E Genden, M Rivera - Mount Sinai Medical Center, NYC, NY
CDX2 Is Rarely Expressed in Columnar Cell Variant of Papillary Thyroid Carcinoma: A Study of Ten Cases.
V Sujoy, A Pinto, CM Kovacs, V Nose - Jackson Memorial Hospital/University of Miami, Miami, FL
Cyclin D1 Expression in Benign and Malignant Differentiated Tumors of the Thyroid Gland.
TP Seybt (1), P Ramalingam, J Huang (2), SW Looney (2), MD Reid - Georgia Health Sciences University, Augusta; Emory University Hospital, Atlanta, GA
Morphoproteomics Demonstrates Activation of mTORC2 in Aggressive Histologic Variants of Papillary Thyroid Carcinoma.
J Liu, RE Brown - University of Texas Health Science Center at Houston Medical School
Potential Role of MAPK Inhibitor in the Benzo(a)pyrene-Induced Anti-Apoptosis Against Cisplatin Treatment and Tumor Tumor Invasion of Papillary Thyroid Carcinoma Cells.
YS Chae, K-S Ahn, H Kim, NH Won - Korea University College of Medicine, Seoul, Korea
Relationship of Mitogen-Activated Protein Kinase and Stromal Reaction in Sporadic Thyroid Malignancies: Role of MAP3K8 in Papillary Carcinomas.
J Moorhead, R Lam, L Lam, A Blanes, SJ Diaz-Cano - King's College Hospital, London, United Kingdom; University of Malaga School of Medicine, Spain
Should Reflexive BRAF Testing Be Performed on Atypical/Borderline Thyroid Nodules?
JD Marotti, JA Lefferts, VA Memoli, AC Golding, GJ Tsongalis, V Padmanabhan - Dartmouth-Hitchcock Medical Center, Lebanon, NH
A Genome-Wide Screening of Promoter DNA Methylation Reveals Differential Profiles of Follicular-Cell Derived Thyroid Neoplasms.
T Kondo, T Nakazawa, T Kawasaki, K Mochizuki, D-F Niu, T Yamane, R Katoh - University of Yamanashi, Chuo, Japan
The Use of Immunohistochemical Expression of SF-1 and EMA in Distinguishing Adrenocortical Tumors from Renal Neoplasms.
ML Enriquez, P Lal, A Ziober, L Wang, JE Tomaszewski, Z Bing - Hospital of the University of Pennsylvania, Philadelphia
Cell Survival in MEN2 Thyroid and Adrenal Medullary Neoplasms: Role of PI3 Kinase/AKT Pathways.
T Ioannidis, R Lam, L Lam, A Blanes, SJ Diaz-Cano - King's College Hospital, London, United Kingdom; University of Malaga School of Medicine, Spain
TRAP-1 Is a New Surrogate Marker for SDH Mutation in Pheochromocytoma/Paraganglioma and a Potential Target for Chemotherapy.
JF Powers, SM Fliedner, I Leav, DC Altieri, K Pacak, AS Tischler - Tufts Medical Center, Boston, MA; NIH/NICHD, Bethesda, MD; University of Massachusetts Medical Center, Worcester; Wistar Institute, Philadelphia, PA
Paradoxal Loss of PDGF-CC Expression in Pheochromocytomas and Paragangliomas.
A Pinto, V Sujoy, U Eriksson, M Neville, V Nose - Jackson Memorial Hospial/University of Miami, Miami, FL; Ludwig Institute for Cancer Research, Karolinska Institute, Stockholm, Sweden
Evaluation of SDHB Immunohistochemistry in the Evaluation of Pheochromocytomas and Paragangliomas from Patients with and without Succinate Dehydrogenase B (SDHB) Mutations.
L Fishbein, K Nathanson, VA LiVolsi, PJ Zhang, KT Montone - University of Pennsylvania, Philadelphia
Immunohistochmical Detection of SSTR2a in Gastro-Entero-Pancreatic Neuroendocrine Tumors (GEPNET) and Response to Somatostatin Analogue (SA).
RY Osamura, H Hirabayashi, M Matsuda, T Itoh - IUHW Mita Hospital, Minato-ku, Tokyo, Japan
Serotonin-Producing EC-Cell Tumors of the Pancreas. Morphological, Immunohistochemical, Ultrastructural and FISH Study of 15 Cases and Comparison with Intestinal EC-Cell Tumors.
S La Rosa, A Perren, A Schmitt, L Albarello, B Bernasconi, G Finzi, C Capella - Ospedale di Circolo, Varese, Italy; University of Berne, Switzerland; San Raffaele Scientific Insitute, Milan, Italy; University of Insubria, Varese, Italy
Heat Shock Protein 90 (HSP90) Expression in Pancreatic Endocrine Neoplasms: A Potential Therapeutic Target and Predictor of Behavior.
AA Gonzalez-Longoria, H Remotti - Columbia University Medical Center, New York, NY
FGFR3 Transcript and Protein Down-Regulation Is a Negative Prognostic Factor and Correlates with Promoter Methylation in Pancreatic Islet Cell Tumors.
M Nassiri, S Ramos, M Jorda - Indiana University School of Medicine, Indianapolis; Univerisity of Miami, FL
Comparison of an Expanded Immunohistochemical Panel To Distinguish High Grade Non-Merkel Cell Neuroendocrine Carcinomas from Merkel Cell Carcinoma.
A Faustin, C Annaiah, D Dhall, B Balzer - Cedars Sinai Medical Center, Los Angeles, CA